Picard Medical, Inc. Files 8-K Report
Ticker: PMI · Form: 8-K · Filed: Oct 27, 2025 · CIK: 2030617
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Picard Medical filed an 8-K on 10/24/25 for Reg FD and financials.
AI Summary
On October 24, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Tucson, Arizona.
Why It Matters
This 8-K filing provides important updates and disclosures for Picard Medical, Inc., which could impact investor understanding of the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report for disclosures and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Picard Medical, Inc. (company) — Registrant
- October 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Tucson, AZ (location) — Address of principal executive offices
- 520-545-1234 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Picard Medical, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 24, 2025.
In which state is Picard Medical, Inc. incorporated?
Picard Medical, Inc. is incorporated in Delaware.
What is the address of Picard Medical, Inc.'s principal executive offices?
The address of Picard Medical, Inc.'s principal executive offices is 1992 E Silverlake, Tucson, AZ, 85713.
What is Picard Medical, Inc.'s telephone number?
Picard Medical, Inc.'s telephone number is (520) 545-1234.
Filing Stats: 429 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-10-24 21:16:47
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PMI The NYSE American, LL
Filing Documents
- picardmedical_8k.htm (8-K) — 30KB
- picardmedical_ex99-1.htm (EX-99.1) — 6KB
- ex99-1_001.jpg (GRAPHIC) — 34KB
- 0001829126-25-008412.txt ( ) — 246KB
- pmi-20251024.xsd (EX-101.SCH) — 3KB
- pmi-20251024_lab.xml (EX-101.LAB) — 33KB
- pmi-20251024_pre.xml (EX-101.PRE) — 22KB
- picardmedical_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 24, 2025, Picard Medical, Inc. issued a press release discussing the volatility of its stock price. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press Release dated October 24, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Picard Medical, Inc. By: /s/ Patrick NJ Schnegelsberg Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer Dated: October 24, 2025 2